Abstract: Many recent image restoration methods use Transformer as the backbone network and redesign the Transformer blocks. Differently, we explore the parameter-sharing mechanism over Transformer ...

Jandas is designed to have very similar indexing experience as Pandas. It implements DataFrame, Series and Index classes in TypeScript and supports position- and label-based indexing. Unlike Pandas ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...

Cathie Wood’s ARK ETF published their daily trades for Friday, December 19th, 2025, showcasing significant activity in several key stocks. Leading the trades was a substantial sale of 23,110 shares of ...

昨日大涨11.4%的Recursion(RXRX.US)盘前续涨3.8%。消息上，摩根大通将Recursion Pharmaceuticals的评级由“中性”上调至“增持”，理由是 ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...

xRFM is a scalable implementation of Recursive Feature Machines (RFMs) optimized for tabular data. This library provides both the core RFM algorithm and a tree-based extension (xRFM) that enables ...

Investing.com - 摩根大通周三将Recursion Pharmaceuticals (NASDAQ:RXRX)评级从"中性"上调至"增持"，同时将目标价从10.00美元上调至11.00美元。该股目前交易价格为4.20美元，根据摩根大通的新目标价，潜在上涨空间超过160%，尽管根据InvestingPro数据显示，该股在过去一周下跌了 ...